Amneal Pharmaceuticals, Inc. (AMRX)

12.16 -0.30 (-2.37%) USD  |  NASDAQ  |  Dec 16, 16:00
12.16 0.00 (0.00%) After-Hours: 19:50
More

Amneal Pharmaceuticals Research and Development Expense (TTM): 205.62M for Sept. 30, 2025

Research and Development Expense (TTM) Chart

View Research and Development Expense (TTM) for AMRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (TTM) Range, Past 5 Years

View Research and Development Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (TTM) Benchmarks

View Research and Development Expense (TTM) Benchmarks
Start Trial
AbbVie, Inc. 8.815B
Johnson & Johnson 15.77B
Amgen, Inc. 6.828B
United Therapeutics Corp. 544.30M
Xeris Biopharma Holdings, Inc. 29.38M